We demonstrated variable prevalence of these two methylation events across cancer types, ranging from rare (e.g. BRCA1 methylation in lung cancer) to highly prevalent (e.g. RAD51C methylation in STAD and BRCA1 methylation in individuals of African ancestry with BC). This evidence concerns the gene BRCA1 and lung carcinoma.